Genome-editing Technologies for Gene and Cell Therapy.
Maeder ML, Gersbach CA. · 2016
Read Genome-editing Technologies for Gene and Cell Therapy. by Maeder ML, Gersbach CA. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4786923.txt.
Description
Morgan L. Maeder and Charles A. Gersbach review genome editing for therapy in Molecular Therapy in 2016. Gene therapy once meant adding a fresh gene and hoping it landed well. Editing tools changed the aim: now the genome itself can be cut and rewritten at a chosen spot, to fix a fault, park a helpful gene safely, or delete a harmful stretch.
The review explains the four cutter families, zinc finger nucleases, TALENs, meganucleases, and the CRISPR/Cas9 system, and how each finds its target. It then tours the uses under study: disarming viruses, arming immune cells against cancer, and repairing single-gene diseases. Delivery, off-target cuts, and control of the edit remain the hard problems, and the authors weigh where the field can go next.
Catalog record
| CREATOR | Maeder ML, Gersbach CA. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 112 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |